MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MÜLLER, W. E.
Right arrow Articles by WOLLERT, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MÜLLER, W. E.
Right arrow Articles by WOLLERT, U.

Molecular Pharmacology, Vol 11, 52-60, Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics

High Stereospecificity of the Benzodiazepine Binding Site on Human Serum Albumin

Studies with d- and l-Oxazepam Hemisuccinate

WALTER E. MÜLLER 1 and UWE WOLLERT 1

1 Pharmakologisches Institut der Universität, D-6500 Mainz, Federal Republic of Germany

Using d- and l-oxazepam hemisuccinate (RV 1208 and RV 1210), the stereospecificity of binding of benzodiazepines to human serum albumin was investigated. The interactions of the two enantiomers of oxazepam hemisuccinate with HSA were examined by gel filtration and circular dichroism measurements at pH 7.4 and 8.2. Both enantiomers, RV 1208 and RV 1210, were bound mainly to one binding site at pH 7.4, but there were great differences in the binding constants. Raising the pH to 8.2 decreased the affinity of RV 1208 and increased the affinity of RV 1210. In both enantiomers complex formation with HSA induced similar extrinsic Cotton effects, the signs of which were partly changed by increasing the pH to 8.2. No ligands other than tryptophan exhibit this high degree of stereospecificity of binding to HSA. A theory for the origin of the stereospecific binding is considered.

Note:
ACKNOWLEDGMENTS The valuable technical assistance of K. Lemmel and B. Lippmann is gratefully acknowledged.

Submitted on June 11, 1974







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics